Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Immulok was a U.S. diagnostics and laboratory products company active in the early 1980s that developed and commercialized immunology, microbiology, and immunofluorescence testing products. Its FDA-cleared product set included viral culture and typing reagents, immunofluorescent antibody assays, tissue immunoperoxidase kits, and radioimmunoassay products, indicating a focus on in vitro diagnostic testing rather than therapeutics. Historical records also show the company held patents on slide-incubation hardware used in immunoassays. The company appears to be inactive today and historical corporate records indicate it was merged out, with later records linking it to Johnson & Johnson-era Raritan, New Jersey addresses. For biotech analysts, Immulok is best understood as a defunct historical diagnostics/medtech company rather than a current drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Immulok.